Score Overview
Explore the 2021 public Archive ranking →
Where Bio-Techne Corp has ranked, year by year
Showing 10 years ranking history by HDB Score.
Reached the top 50 on HDB Score in 9 years, the longest run being 6 in a row — but not in 2021.
- TECH
2000: 2.9% · 2021: 37.6% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 72.51 | — |
1 Year2025-09-26 | $ 51.50 | 40.79% |
5 Years2021-09-28 | $ 118.87 | -39.00% |
10 Years2016-09-28 | $ 25.49 | 184.44% |
20 Years2006-09-28 | $ 10.60 | 6x |
30 Years1996-09-27 | $ 1.16 | 62x |
All Time1989-02-09 | $ 0.09 | 799x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1989-02-09 |
|---|---|---|---|---|---|---|---|
| Price | $ 72.51 | $ 51.50 | $ 118.87 | $ 25.49 | $ 10.60 | $ 1.16 | $ 0.09 |
| Return | — | 40.79% | -39.00% | 184.44% | 6x | 62x | 799x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.21B | $ 181M | $ 264M |
| 2025 | $ 1.21B | $ 73M | $ 162M |
| 2024 | $ 1.15B | $ 168M | $ 152M |
| 2023 | $ 1.13B | $ 285M | $ 204M |
| 2022 | $ 1.10B | $ 272M | $ 247M |
| 2021 | $ 931M | $ 140M | $ 231M |
| 2020 | $ 738M | $ 229M | $ 270M |
| 2019 | $ 714M | $ 96M | $ 166M |
| 2018 | $ 642M | $ 125M | $ 181M |
| 2017 | $ 563M | $ 77M | $ 157M |
| 2016 | $ 499M | $ 104M | $ 95M |
| 2015 | $ 452M | $ 107M | $ 110M |
| 2014 | $ 357M | $ 110M | $ 363M |
| 2013 | $ 310M | $ 112M | $ 332M |
| 2012 | $ 314M | $ 112M | $ 268M |
| 2011 | $ 289M | $ 112M | $ 140M |
| 2010 | $ 269M | $ 109M | $ 138M |
| 2009 | $ 263M | $ 105M | $ 202M |
| 2008 | $ 257M | $ 103M | $ 206M |
| 2007 | $ 223M | $ 85M | $ 164M |
| 2006 | $ 202M | $ 73M | $ 108M |
| 2005 | $ 178M | $ 66M | $ 97M |
| 2004 | $ 161M | $ 52M | $ 176M |
| 2003 | $ 145M | $ 45M | $ 117M |
| 2002 | $ 130M | $ 27M | $ 97M |
| 2001 | $ 115M | $ 34M | $ 97M |
| 2000 | $ 103M | $ 26M | $ 59M |
| 1999 | $ 90M | $ 16M | $ 29M |
| 1998 | $ 67M | $ 15M | $ 27M |
| 1997 | $ 60M | $ 10M | $ 8M |
| 1996 | $ 54M | $ 8M | $ 7M |
| 1995 | $ 47M | $ 6M | $ 5M |
| 1994 | $ 40M | $ 5M | $ 5M |
| 1993 | $ 28M | $ 4M | $ 4M |
| 1992 | $ 22M | $ 2M | $ 4M |
| 1991 | $ 19M | $ 1M | $ 2M |
| 1990 | $ 15M | $ 1M | $ 1M |
| IPO1989 | $ 12M | $ 400K | $ 1M |
Bio-Techne Corp fundamental performance
Between 2021 and 2026, revenue grew from $ 931M to $ 1.21B and net income grew from $ 140M to $ 181M. Revenue increased in 4 of those 5 years; net income in 3.
Across Bio-Techne Corp's full reported history, from 1989 to 2026, revenue grew from $ 12M to $ 1.21B and net income grew from $ 400K to $ 181M. Revenue increased in 95% of the years measured; net income in 76%.
Bio-Techne Corp currently holds a 20-year HDB Score of 5.9 out of 10. How the HDB Score is calculated.
Membership
Continue TECH’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
